Hiroshi Shibata
Overview
Explore the profile of Hiroshi Shibata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
208
Citations
2311
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ohama H, Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, et al.
Sci Rep
. 2025 Jan;
15(1):72.
PMID: 39747852
In the current era of immune therapy, lenvatinib (LEN) continues to be vital for treating unresectable hepatocellular carcinoma (uHCC) patients. This study investigates the importance of nutritional status in the...
2.
Shibata H, Harada T, Ohira H
Front Psychol
. 2024 Sep;
15:1442942.
PMID: 39282685
Interoception, the representation of our bodily state derived from physiological signals, is fundamental to our sense of self. Previous studies using cardiac feedback paradigms demonstrated interoceptive effects on self-perception. However,...
3.
Kitamura B, Iidaka T, Horii C, Muraki S, Oka H, Kawaguchi H, et al.
Osteoarthr Cartil Open
. 2024 Mar;
6(2):100454.
PMID: 38469555
Objective: Considering the joint space width and osteophyte area (OPA) of the knee joints of Japanese adults, this study elucidated the ten-year trends in medial minimum joint space width (mJSW)...
4.
Ohama H, Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, et al.
Oncology
. 2023 Aug;
101(9):542-552.
PMID: 37552968
Introduction: Systemic treatment is generally recommended for Child-Pugh (CP) A status patients with an unresectable hepatocellular carcinoma (uHCC). This study aimed to elucidate differences regarding therapeutic efficacy between lenvatinib (LEN),...
5.
Suzuki T, Komatsu T, Shibata H, Tanioka A, Vargas D, Kawabata-Iwakawa R, et al.
Nucleic Acids Res
. 2023 May;
51(12):6120-6142.
PMID: 37158274
Iron metabolism is closely associated with the pathogenesis of obesity. However, the mechanism of the iron-dependent regulation of adipocyte differentiation remains unclear. Here, we show that iron is essential for...
6.
Araki C, Takemoto D, Kitagawa Y, Tateishi N, Rogi T, Izumo T, et al.
Nutrients
. 2023 Apr;
15(7).
PMID: 37049468
Cellular senescence induces inflammation and is now considered one of the causes of organismal aging. Accumulating evidence indicates that age-related deterioration of mitochondrial function leads to an increase in reactive...
7.
Tomonari T, Tani J, Ogawa C, Deguchi A, Senoh T, Moriya A, et al.
Hepatol Res
. 2022 Oct;
53(2):172-178.
PMID: 36214071
Aim: Cabozantinib (CAB), a multiple kinase inhibitor, has been approved for use in patients with previously treated unresectable hepatocellular carcinoma (uHCC). However, real-world clinical data are lacking, particularly clinical data...
8.
Hiraoka A, Kumada T, Tada T, Hirooka M, Kariyama K, Tani J, et al.
Cancer Med
. 2022 Jun;
12(1):325-334.
PMID: 35666040
Background/aim: A comparison of therapeutic efficacy between atezolizumab plus bevacizumab (Atez/Bev) and lenvatinib treatment given as first-line therapy for unresectable hepatocellular carcinoma (u-HCC) in regard to progression-free survival (PFS) overall...
9.
Ozaki A, Mutsuga M, Kishi E, Abe T, Abe Y, Ando K, et al.
Shokuhin Eiseigaku Zasshi
. 2022 Jun;
63(2):51-61.
PMID: 35650029
Migration test of food utensils, containers, and packaging is an important test method for confirming the safety and their compliance to the standards. However, there is little report on inter-laboratory...
10.
Hatanaka T, Kakizaki S, Hiraoka A, Kariyama K, Tsuji K, Ishikawa T, et al.
Cancer Med
. 2022 May;
12(1):345-357.
PMID: 35608226
Aims: This retrospective study compared the survival between elderly and non-elderly patients. Methods: A total of 5545 treatment-naive patients with hepatocellular carcinoma (HCC) who visited 7 different hospitals from January...